Search

Displaying results 6641 - 6650 of 8974 in total
  1. Drug

    Saredutant

    go.drugbank.com/drugs/DB06660
    Investigational

    Saredutant (SR 48968) is a neurokinin-2 antagonist drug being developed as an antidepressant and anxiolytic by Sanofi-Aventis.

  2. Drug

    Bryostatin 1

    go.drugbank.com/drugs/DB11752
    Investigational

    Bryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease.

  3. Drug

    ALMB-0168

    go.drugbank.com/drugs/DB16926
    Investigational

    ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.

  4. Drug

    AQ-13

    go.drugbank.com/drugs/DB17749
    Investigational

    AQ-13 is an 4-aminoquinoline analog being investigated for the treatment of malaria.

  5. Drug

    Rotigaptide

    go.drugbank.com/drugs/DB13067
    Investigational

    Rotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.

  6. Drug

    Apabetalone

    go.drugbank.com/drugs/DB12000
    Investigational

    Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.

  7. Drug

    Terameprocol

    go.drugbank.com/drugs/DB12226
    Investigational

    Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

    Synonyms: meso-Tetra-O-methylnordihydroguaiaretic acid
  8. Drug

    Fenamole

    go.drugbank.com/drugs/DB12506
    Investigational

    Fenamole has been investigated for the supportive care of Side Effects and Dental Plaque.

  9. Drug

    MG98

    go.drugbank.com/drugs/DB06544
    Experimental

    MG98, a second-generation antisense oligodeoxynucleotide inhibitor of human DNMT1, was investigated in the completed clinical trial NCT00003890 for treating patients with advanced solid tumors.

  10. Drug

    TAFA-93

    go.drugbank.com/drugs/DB05887
    Experimental

    clinical development. mTOR inhibitors are currently used in the prevention of organ rejection in transplantation, the treatment of autoimmune and oncological diseases, and as a component of coated stents for